Medical Neurobiology, Second Edition continues the work of Dr. Peggy Mason as one of the few single author textbooks available. Written in an engaging style for the vast majority of medical students who will choose to specialize in internal medicine, orthopedics, oncology, cardiology, emergency medicine, and the like, as well as the student interested in neurology, psychiatry, or ophthalmology, this textbook provides a sturdy scaffold upon which a more detailed specialized knowledge can be built. Unlike other neuroscience textbooks, this new edition continues to focus exclusively on the human, covering everything from neuroanatomy to perception, motor control, homeostasis, and pathophysiology. Dr. Mason uniquely explains how disease and illness affect one's neurobiological functions and how they manifest in a person. Thoroughly updated as a result of student feedback, the topics are strictly honed and logically organized to meet the needs of the time-pressed student studying on-the-go. This textbook allows the reader to effortlessly absorb fundamental information critical to the practice of medicine through the use of memorable stories, metaphors, and clinical cases. Students will gain the tools and confidence to make novel connections between the nervous system and human disease. This is the perfect reference for any medical student, biology student, as well as any clinician looking to expand their knowledge of the human nervous system. New To the Second Edition of Medical Neurobiology: * New sections on cerebral palsy, brain cancer, traumatic brain injury, neurodegenerative diseases, aphasia, and Kallmann syndrome; * Incorporates easy to understand visual guides to brain development, eye movements, pupillary light reflex, pathways involved in Horner's syndrome; * Presents real-life dilemmas faced by clinicians are discussed from both the medical point of view and the patient's perspective; and * Additional reading lists are provided at the end of each chapter that include first-hand accounts of neurological cases and scientific discoveries (e.g. HM). Key Features Include: * Written in an accessible and narrative tone; * Uses metaphors and clinical examples to help the reader absorb the fundamentals of neurobiology; and * Highly illustrated with over 300 figures and tables for full comprehension of topics covered.

Sjoegren's syndrome is a chronic autoimmune disease which can cause debilitating fatigue and pain. Diagnosis is often challenging due to the variability of symptoms and severity, and a multidisciplinary approach to management and treatment is required, yet there are few comprehensive resources covering everything clinicians need to know. The Oxford Textbook of Sjoegren's Syndrome bridges this gap by offering extensive coverage of system by system manifestations and treatments, as well as practical, evidence-based advice on diagnosing and managing this condition. Bringing together recent advances in research and therapies, this up-to-date guide covers everything clinicians need to know from the fundamental science and clinical characteristics of this condition, to the immunological and biochemical aspects, investigative procedures such as biopsy techniques and imaging modalities, and pharmacological and non-pharmacological interventions.

Rick and Brenda's lives were changed forever when Rick went to the doctor to get a prescription refill. The doctor unexpectedly decided to perform a prostate exam. When he did, he felt a suspicious lump. Weeks later, a biopsy confirmed that Rick had prostate cancer. As a couple, they found their lives changed in unexpected ways following robotic surgery. They decided to share an intimate glimpse into their lives after surgery so other couples would be more prepared than they were. If you are thinking about surgery, or if you just had surgery, you will want to read about their experiences and the life lessons they learned along the way.

This issue of Primary Care: Clinics in Office Practice, Guest Edited by Dr. Mark B. Stephens, is devoted to Cardiovascular Disease. Articles in this issue include: State of the Heart: Overview of disease burden of cardiovascular disease from an epidemiologic perspective; Heavy Heart: Economic burden of heart disease with projections/implications for impact on the health care system; Prevention of Heart Disease; Coronary Artery Disease; Congestive Heart Failure; Valvular Heart Disease; Peripheral Vascular Disease; The Athlete's Heart and Sudden Death; Metabolic Syndrome: systems thinking in heart disease; Women and Heart Disease; Heart Disease in Children; and Cardiac Imaging.

The Management of Lithiasis: The Rational Deployment of Technology addresses the latest developments in the treatment of urolithiasis and biliary stones. The emphasis of the book is on the selection of the cheapest and most effective treatment and is based upon the experience of editors and authors from both the Western countries as well as developing countries in Asia. With health care budgets becoming increasingly restricted, there is a growing interest in cost-controlled and effective treatment methods. This volume covers urinary tract calculi as well as biliary tract calculi, including epidemiology, etiology, choices in the management of calculi, efficacy and safety of treatment and the prevention of urolithiasis.

Despite what you may have read in the popular press and in social media, Precision Medicine is not devoted to finding unique treatments for individuals, based on analyzing their DNA. To the contrary, the goal of Precision Medicine is to find general treatments that are highly effective for large numbers of individuals who fall into precisely diagnosed groups. We now know that every disease develops over time, through a sequence of defined biological steps, and that these steps may differ among individuals, based on genetic and environmental conditions. We are currently developing rational therapies and preventive measures, based on our precise understanding of the steps leading to the clinical expression of diseases. Precision Medicine and the Reinvention of Human Disease explains the scientific breakthroughs that have changed the way that we understand diseases, and reveals how medical scientists are using this new knowledge to launch a medical revolution.

Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Tourette's syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually. This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers. By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.

This book is the one I wish I'd come across when I joined the fraternity or soon thereafter. It takes a hard look at some of the non-medical issues you may not have thought about. If it has succeeded, you'll recognize them when they turn up in your life. You'll learn how some other men have dealt with them and get ideas about how you might manage them in your own way. Not least, you'll discover some new ways to think about your situation.

What this book is not about is treating prostate cancer. There are countless volumes on that topic. It's about dealing and living with prostate cancer; about handling unfamiliar situations that are going to arise; about regaining a sense of control; about living productively, well and yes, happily to the outerlimits of possibilities.

In 2011 the world was shocked when the news broke that Joost van der Westhuizen, known for years as the golden boy of South African rugby and a former Springbok captain, had been diagnosed with motor neuron disease (MND).

This rare condition attacks the central nervous system, causing progressive disability. There is no known cure. All who have seen Joost in action will know that he is not one to give up without a fight. His game-changing prowess as a brilliant scrum half is now focused on a battle for survival and, more importantly, on making a difference to the lives of others with the disease. In a race against time, Joost has a dream to fulfil. He says: “In the beginning you go through all the emotions and you ask, ‘Why me?’ It’s quite simple. ‘Why not me?’ If I have to go through this to help future generations, why not me?” His acceptance of his symptoms is equally pragmatic: “One day you can’t move your arm, another day you don’t have speech. Every day you are reborn and you take the day as it comes.”

Glory Game – The Joost van der Westhuizen Story is a compelling narrative of redemption set against the backdrop of an illustrious career in rugby. It is the story of a modern-day warrior forced to face his own human frailty. Joost shows us that beyond ambition, success and fame lies the true wealth of family and friends, and that within a ravaged body the spirit can remain invincible.

This issue of Medical Clinics, guest edited by Drs. Michael P. Pignone and Kirsten Bibbins-Domingo, is devoted to Disease Prevention. Articles in this issue address prevention for various diseases, including: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer; and Screening for Depression. Lipids, CV Risk Assessment, Blood Pressure, and Aspirin for Primary Prevention will also be addressed.

This book is an amalgamation of knowledge, experience, and expertise in various aspects of nanotechnology, by experts who are proficient in designing of novel nanoformulations that are used in the treatment of various challenging and prevalent diseases. It is an exhaustive compilation of the multi-faceted arena of nanoformulations and the healthcare system that caters to the needs of academicians, scholars, researchers etc. The most important aspect of the book covers various types of nanoformulations and their applications in treatment of communicable and non-communicable diseases. Each chapter focuses on a particular nanoformulation as well as a disease including the pathophysiology of the disease, the current treatment modalities of diseases, the role of nanoformulation in treatment and other future aspects and directions for further work. Coverage includes neuropathic pain, colon targeting, nose-to-brain drug delivery, skin cancer, arthritis and tuberculosis.

This issue of the Cardiac Electrophysiology Clinics, edited by Drs. Amin Al- Ahmad and Francis Marchlinski, will cover Ventricular Tachycardia in Structural Heart Disease. Topics discussed in the issue include, but are not limited to, ECG localization of VT in patients with structural heart disease; Anatomy for VT ablation in structural heart disease; Ablation of VT in ischemic and non-ischemic heart disease; Pace mapping; Ablation of VT in ARVD; Epicardial VT ablation; and VT clinical trials, among others.

This issue of Clinics in Chest Medicine focuses on Viral and Atypical Pneumonia. Editors Charles Dela Cruz and Richard Wunderlink have assembled an expert team of authors on topics such as: Epidemiology of Viral Pneumonia; Diagnostic Testing for Viral and Atypical Infections;Lung Microbiome: Atypical Infections and Viruses; RSV Pneumonia in the Young and Old;Viral infections in Chronic Lung Diseases; Viral Pneumonia and ARDS;Viruses in the Immunocompromised; Atypical Bacterial Pneumonia; Other Community Respiratory Viruses; Pandemic Viruses; Epidemic and Emerging Coronaviruses; Post-Viral Complications; Antiviral Treatments; and Vaccines in the Prevention of Viral Pneumonia.

This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Albert Shieh of UCLA, is devoted to Bone Disorders. Articles in this outstanding issue include: Role of Osteocyte in Bone and Non-Bone Disease; Bone-Fat Interaction; Imaging Beyond DXA; Vitamin D in African-Americans; Pre-Menopausal Osteoporosis; Combined Pharmacologic Therapy in Osteoporosis; Drug-Related Adverse Events in Osteoporosis; Novel Therapies for Osteoporosis; Diabetes and Bone Disease; Bariatric Surgery and Bone Metabolism; Hyperparathyroidism and Bone Microarchitecture; FGF-23 Mediated Bone Disease; and Endothelin-Related Bone Disorder.

Chronic Medical Disease and Cognitive Aging: Toward a Healthy Body and Brain explores the important and often overlooked connection between how chronic medical diseases of the body can affect cognitive function and brain health. As population demographics shift to that of an aging population it has become more important to understand and improve cognitive function in late life. Chronic medical diseases often increase the risk of cognitive impairment, and those with cognitive impairment may be less able to effectively manage their medical conditions, suggesting a reciprocal relationship may exist where medical disease impacts cognition that in turn may exacerbate physical health. Chronic Medical Disease and Cognitive Aging discusses current research on the association between a variety of chronic medical diseases and cognition and, where appropriate, promising interventions or accepted treatment strategies. While a cure for many diseases continues to be elusive, insights garnered from the interplay between diseases of the body and mind may help point the way to novel therapeutic strategies to improve cognitive function in late life.

Neuroendocrine Factors in Ulcer Pathogenesis: Role of Sensory Neurons in the Control of Gastric Mucosal Blood Flow and Protection; P. Holzer, et al. Sympathoadrenergic Regulation of Duodenal Mucosal Alkaline Secretion; L. Fandriks, C. Joenson. Potentiation of Intestinal Secretory Responses to Histamine: Pathophysiological Implications; P. Rangachari, et al. Braingut Interactions in Ulcer Pathogenesis: Neuroendocrine Control of Gastric Acid Secretion; Y. Osumi. Corticotropinreleasing Factor in Stressinduced Changes in Gastrointestinal Transit; T. Burks. Stress, Corticotrophinreleasing Factor; (CRF) and Gastric Function; H. Weiner. Novel Therapeutic Approaches to Gastrointestinal Ulceration: The Gastric Mucosal Barrier: A Dynamic, Multifunctional System; A. Garner, et al. New Approaches to Gastroprotection: Calcium Modulators; G.B. Glavin, A.M. Hall. Efficacy of Dopaminergic Agents in Peptic Ulcer Healing and Relapse Prevention: Further Indication of the Importance of Stomach Dopamine in the Stressorganoprotection Concept; P. Sikiric, et al. Dietary Factors Influencing Gastrointestinal Ulceration: The Luminal Regulatory System; F. Guarner, et al. 14 additional articles. Index.

The Neuronal Ceroid Lipofuscinoses is a lysosomal disease which have recently been confirmed by important genetic studies on the NCL which revealed a diversity of at least 8 gene loci related to this group of diseases. ECA-"NCL" represents a multi-national, multi-disciplinary network of researchers on the NCL which have provided new data on this group of diseases. In this book, clinical features, neuroradiological and electrophysiological data, morphological aspects, genetic data and biochemical results will be provided. This book is written for active researchers on NCL and other lysosomal and neurodegenerative diseases, as well as for those interested in NCL for other reasons, foremost patients (and their parents). Tables, illustrations, and most recent references will accompany the text produced and edited by an editorial board consisting of participants of this ECA-"NCL." At the end of this presentation, future lines of research including therapies - will be outlined and emphasized what will have to be done to arrive at complete elucidation of this group of progressive neurodegenerative disorders.